GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OTCPK:ORXOY) » Definitions » Tax Provision

Orexo AB (Orexo AB) Tax Provision : $0.77 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Orexo AB Tax Provision?

Orexo AB's tax provision for the three months ended in Mar. 2024 was $0.09 Mil. Its tax provision for the trailing twelve months (TTM) ended in Mar. 2024 was $0.77 Mil.

Orexo AB Tax Provision Historical Data

The historical data trend for Orexo AB's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Tax Provision Chart

Orexo AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.93 -5.51 -0.11 -0.69 1.17

Orexo AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.30 0.30 0.09 0.09

Orexo AB Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orexo AB (Orexo AB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OTCPK:ORXOY) » Definitions » Tax Provision
Comparable Companies
OSTO:ENZY OSTO:MOB OSTO:VIVE XSAT:DICOT OSTO:ERMA OSTO:ALZCUR OSTO:TOL OSTO:NANEXA OSTO:NEWBRY XSAT:ODI ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA TSE:4507 VTRS NBIX XSWX:SDZ
Traded in Other Exchanges
ORXOF:USA ORX:Sweden 0H19:UK C5G:Germany
Address
Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105
Website
https://www.orexo.com
Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments US Pharma, Digital Therapeutics (DTx) and HQ & Pipeline. The majority is from the US Pharma segment. Geographically, the majority is derived from the United States. US Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline include the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.